Recent Updates
Recently added Catalysts
RDY Neutral Sentiment Score: 50/100

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co

Key Takeaway: Dr. Reddy's Laboratories Ltd. has provided audio recordings of its earnings call for the first quarter of fiscal year 2025, which was conducted on July 27, 2024. The company is in compliance with the Securities and Exchange Board of India regulations by disclosing this information. The audio recordings are available through a provided web link for stakeholders to access.

Market Sentiment Analysis

Full Press Release Details

National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)
BSE Limited (Stock Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Sub: Audio Recordings of the Earnings call conducted on July 27,
Pursuant to Regulation 30 of the Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the link of the audio recordings
of the Earnings call for the quarter ended June 30, 2024, conducted on July 27, 2024.
This is for your information and records.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer &

Frequently Asked Questions

When was the earnings call conducted?

The earnings call took place on July 27, 2024.

What is the web link to the earnings call audio?

The audio recording can be accessed at the provided web link.

What quarter does the earnings call report cover?

The earnings call covers the quarter ended June 30, 2024.

Who is the compliance officer for Dr. Reddy's?

The compliance officer is listed as the Company Secretary.

Last updated: Jul 27, 2024